News
TipRanks on MSN4h
Cytokinetics presents additional data related to AficamtenCytokinetics (CYTK) announced that additional data arising from two analyses from SEQUOIA-HCM, the pivotal Phase 3 clinical trial of aficamten in ...
with Mild and Moderate-to-Severe Symptoms, and Across Geographic Regions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback